Skip to content
Simpler Grants

No. HT942526TBDRPTDRA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

grants.gov listing Full announcement (NOFO)
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Award range
Not specified
Expected awards
~2
Application deadline
Oct 22, 2026
Posted
May 5, 2026
Last verified
Yesterday

At a glance

AI summary

This program funds product-driven therapeutic and diagnostic research on Lyme disease and other tick-borne diseases and conditions, with the goal of improving patient care and quality of life. Eligible applicants include extramural and intramural U.S. Department of War organizations, as well as foreign and domestic for-profit, nonprofit, public, and private organizations; awards are made to eligible organizations, not individuals. The program expects to fund about two awards, with a total cost cap of $1.325 million per award and a maximum project period of 3 years. Cost sharing is not required, and applications must focus on Lyme disease and/or other tick-borne diseases, with emphasis on persistent Lyme disease and other U.S.-endemic tick-borne diseases; clinical trials are not allowed.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Technology & Product Development
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings. https://cdmrp.health.mil/pubs/press/2026/tbdrppreann

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097 — —
FY 2023 1,115 — —
FY 2022 1,186 — —
FY 2021 1,023 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026